At a glance
ClinicalIndex Comparison RecordN/ACompleted· 86 enrolled
Drug / intervention
DT1fAdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Performance of Dailies Total1® Contact Lenses for Astigmatism in Symptomatic Habitual Reusable Toric Lens Wearers
In Brief
An observational study evaluating DT1fA for Astigmatism. Completed, enrolled 86 participants across 1 site.
Detailed Summary
To subjectively evaluate Dailies Total1® contact lenses for astigmatism (DT1fA) performance compared to other common weekly/monthly contact lenses in symptomatic patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAstigmatism
CountriesUnited States
CollaboratorsSengi
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartAug 2022
First PostedAug 2022
Primary CompletionDec 2022
TodayJul 2026
First PostedAug 12, 2022
Enrollment StartAug 2, 2022
Primary CompletionDec 16, 2022
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.9 years ago
Interventions
DT1fAdevice
DT1fA contact lenses